Tentech announced on the 12th that it showcased its key products at the Aesthetic & Anti-Aging Medicine World Congress Japan 2024 (AMWC JAPAN 2024) held at the ANA InterContinental Hotel in Tokyo, enhancing its credibility in the global market.

At this congress, Tentech focused on its flagship devices, 10THERMA and 10TRIPLE, laying the groundwork for expansion into the Japanese and broader Asian markets. On the first day, Dr. Jong-Seo Kim hosted a luncheon seminar with a lecture titled "Lifting Effects on Five Facial Zones through 3D Analysis," which was well received. He emphasized the technological superiority of 10THERMA and 10TRIPLE, successfully communicating Tentech's strategy for entry into the Japanese market.

Tentech's latest devices garnered significant attention at the exhibition. Set for launch early next year, the 10TRIPLE, is a three-line HIFU device equipped with four types of handpieces—3-line, 3-dot, and 1-dot—to significantly reduce treatment time while enhancing patient satisfaction, according to the company.

The 10THERMA, according to Tentech, features a maximum output of 400W and offers tips tailored for various treatment areas such as face, eyes, and body. The 5cm² face tip, in particular, covers 25% more area than the company's previous tips, allowing for faster and more effective treatments. 10THERMA's Smart Temperature Cooling (S.T.C) system and impedance-matching technology prevent skin damage and provide customized energy delivery for enhanced safety. The device has also earned FDA (USA) approval, underscoring its reliability.

Tentech’s CEO Dong-Ok Han remarked, "During the event, representatives from various countries, including Japan, Singapore, Taiwan, and Indonesia, visited the Tentech booth, fostering vibrant exchanges. This was an opportunity to confirm Tentech’s global network and brand power. With 10THERMA and 10TRIPLE, we aim to make a strong push into the Japanese market and elevate our brand value worldwide."

Through its participation in AMWC JAPAN 2024, Tentech intends to solidify its presence in the Asian market and continue its growth in the global anti-aging and aesthetic medical device industry.